Ligne de temps
Laurine Levillayer
Technicien(ne)
01 oct. 2024
publication
Zika virus T-cell based 704/DNA vaccine promotes protection from Zika virus infection in the absence of neutralizing antibodies.
Lire plus01 janv. 2024
publication
Role of two modules controlling the interaction between SKAP1 and SRC kinases comparison with SKAP2 architecture and consequences for evolution.
Lire plus03 févr. 2023
publication
Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants.
Lire plus21 nov. 2022
publication
SKAP2 modular organization differently recognizes SRC kinases depending on their activation status and localization.
Lire plus01 déc. 2021
publication
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.
Lire plus29 sept. 2021
09 oct. 2020
21 juin 2019
publication
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice
Lire plus11 oct. 2018
project
miRNA involvement in resistance to infection by Dengue virus : miRNA transcriptome on monocytes of individuals “Susceptible” or “Resistant” following in vitro infection by DENV2
Lire plus08 oct. 2018
08 oct. 2018
project
T cell immunity to dengue virus infection in transgenic mice expressing human HLA molecules
Lire plus11 mai 2015